Literature DB >> 19805707

End-of-life decisions in Dutch neonatal intensive care units.

A A Eduard Verhagen1, Jozef H H M Dorscheidt, Bernadette Engels, Joep H Hubben, Pieter J Sauer.   

Abstract

OBJECTIVE: To clarify the practice of end-of-life decision making in severely ill newborns.
DESIGN: Retrospective descriptive study with face-to-face interviews.
SETTING: The 10 neonatal intensive care units in the Netherlands from October 2005 to September 2006. PATIENTS: All 367 newborn infants who died in the first 2 months of life in Dutch neonatal intensive care units. Adequate documentation was available in 359 deaths. OUTCOME MEASURES: Presence of end-of-life decisions, classification of deaths in 3 groups, and physicians' considerations leading to end-of-life decisions.
RESULTS: An end-of-life decision preceded death in 95% of cases, and in 5% treatment was continued until death. Of all of the deaths, 58% were classified as having no chance of survival and 42% were stabilized newborns with poor prognoses. Withdrawal of life-sustaining therapy was the main mode of death in both groups. One case of deliberate ending of life was found. In 92% of newborns with poor prognoses, end-of-life decisions were based on patients' future quality of life and mainly concerned future suffering. Considerations regarding the infant's present state were made in 44% of infants.
CONCLUSIONS: Virtually all deaths in Dutch neonatal intensive care units are preceded by the decision to withdraw life-sustaining treatment and many decisions are based on future quality of life. The decision to deliberately end the life of a newborn may occur less frequently than was previously assumed.

Entities:  

Mesh:

Year:  2009        PMID: 19805707     DOI: 10.1001/archpediatrics.2009.166

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  17 in total

1.  Research governance and change in research ethics practices at a major Australian university.

Authors:  Yordanka Krastev; Michael Grimm; Andrew Metcalfe
Journal:  Monash Bioeth Rev       Date:  2011-09

Review 2.  Knowing when to stop: futility in the ICU.

Authors:  Dominic J C Wilkinson; Julian Savulescu
Journal:  Curr Opin Anaesthesiol       Date:  2011-04       Impact factor: 2.706

3.  Involuntary euthanasia of severely ill newborns: is the Groningen Protocol really dangerous?

Authors:  P Voultsos; F Chatzinikolaou
Journal:  Hippokratia       Date:  2014 Jul-Sep       Impact factor: 0.471

4.  Children's outcomes at 2-year follow-up after 4 years of structured multi-professional medical-ethical decision-making in a neonatal intensive care unit.

Authors:  J C de Boer; L Gennissen; M Williams; M van Dijk; D Tibboel; I Reiss; S Naghib; J Sol
Journal:  J Perinatol       Date:  2017-03-30       Impact factor: 2.521

5.  Neonatal euthanasia: The Groningen Protocol.

Authors:  Felipe E Vizcarrondo
Journal:  Linacre Q       Date:  2014-11

6.  Mode of neonatal death in an Irish maternity centre.

Authors:  Daragh Finn; Aedin Collins; Brendan P Murphy; Eugene M Dempsey
Journal:  Eur J Pediatr       Date:  2014-06-11       Impact factor: 3.183

7.  Integrating neurocritical care approaches into neonatology: should all infants be treated equitably?

Authors:  P C Mann; S M Gospe; K J Steinman; B S Wilfond
Journal:  J Perinatol       Date:  2015-08-06       Impact factor: 2.521

8.  A life worth giving? The threshold for permissible withdrawal of life support from disabled newborn infants.

Authors:  Dominic James Wilkinson
Journal:  Am J Bioeth       Date:  2011-02       Impact factor: 11.229

9.  Living with a crucial decision: a qualitative study of parental narratives three years after the loss of their newborn in the NICU.

Authors:  Laurence Caeymaex; Mario Speranza; Caroline Vasilescu; Claude Danan; Marie-Michèle Bourrat; Micheline Garel; Catherine Jousselme
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

10.  Impact of a palliative care program on end-of-life care in a neonatal intensive care unit.

Authors:  N Younge; P B Smith; R N Goldberg; D H Brandon; C Simmons; C M Cotten; M Bidegain
Journal:  J Perinatol       Date:  2014-10-23       Impact factor: 3.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.